First Databank is First Clinical Decision Support Provider to Receive NICE Accreditation

First DatabankFirst Databank (FDB) has become the first drug knowledge base and clinical decision support provider to be awarded accreditation by NICE's Accreditation Programme. The NICE Accreditation Advisory Committee made its decision based on the process used to develop the clinical and medicines' information and the editorial rigour implemented across FDB's drug knowledge database, which underpins its products Multilex and FIRSTLight.

The accreditation process ensures a thorough and transparent evaluation, including technical analysis, peer review and consideration by an advisory committee of guidance experts. The pilot application included further review by Dr Maureen Baker, clinical director of patient safety at NHS Connecting for Health, and a team of safety engineers.

In a time when the public sector is charged with making significant efficiency improvements and achieving challenging NHS reforms, NICE’s role in providing recommendations to organisations in the public and private sector is of critical importance. This accreditation helps health and social care professionals identify the most robustly produced clinical decision support available, driving up the quality of care delivery. FDB is the only drug knowledge provider that has been given accreditation.

The accreditation assessment reviewed the processes that FDB uses to develop the clinical decision support content within its products, Multilex and FIRSTLight. The Multilex drug terminology holds clinical and commercial information on more than 75,000 pharmaceutical products and packs, and both products provide active clinical decision support and referential medicines information for all healthcare professionals, as well as endorsing and reimbursement support for community pharmacists and dispensing doctors.

NICE's accreditation of FDB's processes to develop the content in its clinical decision support, in parallel with the Connecting for Health assessment of the technology and the recommendations delivered in specific clinical settings, provides NHS organisations with reassurance of the overall quality of the clinical decision support system they are purchasing.

Darren Nichols, managing director of First Databank explains further; "FDB has led the way in having independent validation by NICE of the processes used in our drug knowledge and clinical decision support that forms the core of our product offering to the UK and International healthcare markets. The quality of our knowledge base, provided by our expert clinicians, researchers and health informaticists, means that Healthcare IT system vendors, and clinicians using our drug data within those systems, can have complete confidence in the clinical decision support we offer."

The NICE accreditation lasts for five years from the date of award.

Related news articles:

About First DataBank
First DataBank is the UK's leading provider of drug knowledge bases and active clinical decision support. With over 30 years' experience of maintaining, developing and integrating drug knowledge bases across the entire healthcare spectrum, First DataBank has unrivalled expertise and knowledge in this specialist field. NHS Connecting for Health has chosen First DataBank to provide drug-related clinical decision support.

Patient safety is the driving force behind our business. Through the effective integration of our products into clinical systems, we enable safer prescribing, dispensing and administration.

Our Multilex Drug Data File - the UK's most comprehensive and widely used drug knowledge base - is in daily use by thousands of healthcare professionals in the UK.

For further information visit www.firstdatabank.co.uk.

Most Popular Now

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Medical Receptionist Modernizing Doct…

A virtual medical receptionist named "Cassie," developed through research at Texas A&M University, is transforming the way patients interact with health care providers. Cassie is a digital-human assistant created by Humanate...

Using Data and AI to Create Better Healt…

Academic medical centers could transform patient care by adopting principles from learning health systems principles, according to researchers from Weill Cornell Medicine and the University of California, San Diego. In...

Northern Ireland Completes Nationwide Ro…

Go-lives at Western and Southern health and social care trusts mean every pathology service is using the same laboratory information management system; improving efficiency and quality. An ambitious technology project to...

AI Detects Hidden Heart Disease Using Ex…

Mass General Brigham researchers have developed a new AI tool in collaboration with the United States Department of Veterans Affairs (VA) to probe through previously collected CT scans and identify...

AI Tool Set to Transform Characterisatio…

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better characterise the diversity of individual cells within...

Human-AI Collectives Make the Most Accur…

Diagnostic errors are among the most serious problems in everyday medical practice. AI systems - especially large language models (LLMs) like ChatGPT-4, Gemini, or Claude 3 - offer new ways...

Highland Marketing Announced as Official…

Highland Marketing has been named, for the second year running, the official communications partner for HETT Show 2025, the UK's leading digital health conference and exhibition. Taking place 7-8 October...

MHP-Net: A Revolutionary AI Model for Ac…

Liver cancer is the sixth most common cancer globally and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is a crucial step for the management of the...

Groundbreaking TACIT Algorithm Offers Ne…

Researchers at VCU Massey Comprehensive Cancer Center have developed a novel algorithm that could provide a revolutionary tool for determining the best options for patients - both in the treatment...

The Many Ways that AI Enters Rheumatolog…

High-resolution computed tomography (HRCT) is the standard to diagnose and assess progression in interstitial lung disease (ILD), a key feature in systemic sclerosis (SSc). But AI-assisted interpretation has the potential...